Trials / Unknown
UnknownNCT00970398
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
Effect of Infant Formula With Bovine Milk Osteopontin on Infant Growth, Health and Immune functions-a Double-blind Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Biostime, Inc. · Industry
- Sex
- All
- Age
- 1 Day – 30 Days
- Healthy volunteers
- Accepted
Summary
The specific objectives of this study are to evaluate the effects of bovine milk osteopontin added to infant formula on infant growth, health and immune functions.
Detailed description
Breast-fed infants will be used as a reference group and formula-fed infants will be fed control formula or the same formula supplemented with Osteopontin at a concentration 50% or 100% of that of breast milk. The hypothesis is that supplementation of bovine milk Osteopontin in infant formula will have positive effects on infant growth, health and immune functions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Infant formula supplemented with bovine milk Osteopontin | Infant formula supplemented with bovine milk osteopontin at 50% and 100% levels of that of breast milk respectively. |
| OTHER | Standard infant formula | Infant formula without supplementation of bovine milk Osteopontin |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-09-01
- Completion
- 2013-07-01
- First posted
- 2009-09-02
- Last updated
- 2013-04-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00970398. Inclusion in this directory is not an endorsement.